Biblio
Export 224 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is L [Clear All Filters]
“Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 597-606, 2018.
, “APOEɛ4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.”, J Alzheimers Dis, vol. 86, no. 1, pp. 155-171, 2022.
, “Interrelationship between the Levels of C9orf72 and Amyloid-β Protein Precursor and Amyloid-β in Human Cells and Brain Samples.”, J Alzheimers Dis, vol. 62, no. 1, pp. 269-278, 2018.
, “Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 67, no. 2, pp. 725-735, 2019.
, “Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.
, “Head Position During Sleep: Potential Implications for Patients with Neurodegenerative Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 631-638, 2019.
, “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
, “Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1259-1272, 2016.
, “Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”, J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
, “Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 813-822, 2017.
, “Frequency-Dependent Changes in the Amplitude of Low-Frequency Fluctuations in Mild Cognitive Impairment with Mild Depression.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1175-1187, 2017.
, “Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review.”, J Alzheimers Dis, vol. 57, no. 1, pp. 29-36, 2017.
, “Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.”, J Alzheimers Dis, vol. 58, no. 2, pp. 361-371, 2017.
, “Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.”, J Alzheimers Dis, vol. 54, no. 1, pp. 135-48, 2016.
, “miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
, “The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1269-1282, 2017.
, “Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.”, J Alzheimers Dis, vol. 64, no. 1, pp. 205-221, 2018.
, “Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China.”, J Alzheimers Dis, vol. 49, no. 1, pp. 139-47, 2016.
, “Sirtuin 3 Mediates Tau Deacetylation.”, J Alzheimers Dis, vol. 69, no. 2, pp. 355-362, 2019.
, “Vascular Cognitive Impairment and the Gut Microbiota.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1209-1222, 2018.
, “Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1403-1417, 2017.
, “S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-β Through Modulation of Glutathione Metabolism.”, J Alzheimers Dis, vol. 58, no. 2, pp. 549-558, 2017.
, “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
, “TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β.”, J Alzheimers Dis, vol. 63, no. 2, pp. 761-772, 2018.
, “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
,